MARIA ISABEL FORCADAS BERDUSAN-rekin lankidetzan egindako argitalpenak (46)

2012

  1. Successful outcome of episodes of status epilepticus after vagus nerve stimulation: A multicenter study

    European Journal of Neurology, Vol. 19, Núm. 9, pp. 1219-1223

2011

  1. Predictive factors for a good prognosis following surgery for temporal lobe epilepsy: A cohort study in Spain

    Epileptic Disorders, Vol. 13, Núm. 1, pp. 36-46

2009

  1. Malformations and fetal death in the Spanish antiepileptic drug and pregnancy registry: Results at 6 years

    Neurologia, Vol. 24, Núm. 6, pp. 360-365

  2. Neuroleptic malignant syndrome and serotonin syndrome in a female patient: A clinicopathologic case

    Clinical Neuropharmacology, Vol. 32, Núm. 5, pp. 299-300

2008

  1. A retrospective study of the effectiveness of lamotrigine in monotherapy for the treatment of epileptic seizures. The ERELMO study

    Revista de Neurologia, Vol. 46, Núm. 4, pp. 197-202

2007

  1. Central hypoventilation as the presenting symptom in Hu associated paraneoplastic encephalomyelitis

    Journal of Neurology, Neurosurgery and Psychiatry, Vol. 78, Núm. 10, pp. 1143-1145

  2. Oxcarbazepina en el tratamiento de la epilepsia focal refractaria

    Gaceta médica de Bilbao: Revista oficial de la Academia de Ciencias Médicas de Bilbao. Información para profesionales sanitarios, Vol. 104, Núm. 1, pp. 20-22

  3. Special situations in epilepsy: Women and the elderly

    Neurologist, Vol. 13, Núm. 6 SUPPL. 1

2006

  1. Ambiguous epileptic syndrome: From the point of view of adults

    Revista de Neurologia

  2. Tau-predominant-associated pathology in a sporadic-late-onset Hallervorden-Spatz syndrome

    Movement Disorders, Vol. 21, Núm. 1, pp. 107-111

2005

  1. A novel mutation (K317M) in the MAPT gene causes FTDP and motor neuron disease

    Neurology, Vol. 64, Núm. 9, pp. 1578-1585

  2. A randomised open-label study of tiagabine given two or three times daily in refractory epilepsy

    Seizure, Vol. 14, Núm. 2, pp. 81-84

  3. Cerebrovascular disease in a tertiary care hospital. Current situation and issues to be improved

    Revista de Neurologia, Vol. 40, Núm. 12, pp. 723-728

  4. Classic antiepileptic and new generation antiepileptic drugs: Gender differences in effectiveness and adverse drug reactions

    Neurologia, Vol. 20, Núm. 2, pp. 71-76

  5. Familial prion diseases in the basque country (Spain)

    Neuroepidemiology, Vol. 24, Núm. 1-2, pp. 103-109

  6. Fármacos antiepilépticos clásicos y de nueva generación: Diferencias de sexo en la efectividad

    Neurologia

  7. Phenotypic variability in familial prion diseases due to the D178N mutation

    Journal of Neurology, Neurosurgery and Psychiatry, Vol. 76, Núm. 11, pp. 1491-1496

2004

  1. Safety of levetiracetam as adjunctive therapy in epilepsy: The skate trial in Spain

    Revista de Neurologia, Vol. 38, Núm. 12, pp. 1117-1122

2003

  1. Condicionamiento laboral, social y legal de las personas con epilepsia

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 8, Núm. 95, pp. 5173-5176

  2. Peculiaridades clínicas y de manejo terapéutico de la epilepsia en la mujer y en el anciano

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 8, Núm. 95, pp. 5135-5140